Introducing the new AltIndexLearn more
$69,000 1.3%
Total revenue, Q2 '26 ().

Did Mangoceuticals Beat Earnings?

Mangoceuticals (MGRX) reported Q2 '26 revenue of $69,000, down 59.1% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Mangoceuticals’s job postings, web traffic, and employee business outlook. See the full MGRX stock analysis or the earnings calendar for upcoming reports.

Mangoceuticals Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue130,000110,000110,000170,00084,00094,00068,00069,000
Gross margin62.0%76.1%56.8%53.5%60.4%50.3%42.7%64.3%
Operating margin-1,318.2%-1,594.3%-4,440.0%-3,134.0%-8,953.5%-1,579.5%-4,606.8%-1,502.5%
Net income-2M-1.9M-4.8M-5.4M-7.6M-2.8M-3.4M-1.3M
Net margin-1,498.9%-1,850.9%-4,427.4%-3,221.6%-9,042.8%-2,935.1%-5,014.6%-1,909.1%
EPS

Mangoceuticals Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Mangoceuticals’s quarterly revenue moved from $130,000 to $69,000. Net margin compressed from -1498.9% to -1909.1%, against a 64.3% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit.

When Is Mangoceuticals’s Next Earnings Date?

Mangoceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the MGRX earnings calendar.

Frequently Asked Questions: Mangoceuticals Earnings

Mangoceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Mangoceuticals reported Q2 '26 revenue of $69,000, down 59.1% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the MGRX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.